Allessa plant to be upgraded
WeylChem has announced that it is investing a sum “in the range of high single-digit millions euros” to upgrade a multi-purpose plant at the site of its Allessa custom and toll manufacturing subsidiary.
Feature article - Canary in the coalmine?
Carolyn Buller of Squire Patton Boggs offers her perspective on the state of the industry at the turn of the decade.
Lonza swings to pharma
Lonza has announced results for 2019, in which its growth was entirely driven by the Pharma Biotech & Nutrition division on which it will base its future.
Regulatory alignment vital, says CBA
The Chemical Business Association, which represents chemical distributors in the UK, has joined other associations in responding critically to Chancellor Sajid Javid’s recent statement that there would be no regulatory alignment with the EU following Brexit.
Piramal to expand Canadian facility
CDMO Piramal Pharma Solutions business is to expand its Aurora facility in Aurora, Toronto, by investing C$25 million in a new API wing.
Lanxess pushes forward site digitisation
Lanxess has implemented Software AG’s TrendMiner self-service analytics system for time-series data in about two thirds of its 120 plants, including all of its major production sites in Germany, Belgium, the US and India. Only smaller plants with less complex processes are not yet covered, the company said.
Clariant Refinery Services opens UK lab
Clariant Refinery Services officially opened a new crude and fuel oil laboratory at Bradford, UK, on 23 January. This division makes pour point depressants (PPDs) for the transportation and storage of crude oil, diesel and marine fuels; and cold-flow additive applications for middle-distillates, including diesel, home heating oil and biofuels.
